Vaxil Bio (TSXV:VXL) ROE % Adjusted to Book Value : 3.33% (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio ROE % Adjusted to Book Value?

Vaxil Bio's ROE % for the quarter that ended in Dec. 2023 was 11.88%. Vaxil Bio's PB Ratio for the quarter that ended in Dec. 2023 was 3.57. Vaxil Bio's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 3.33%.

Vaxil Bio ROE % Adjusted to Book Value Historical Data

The historical data trend for Vaxil Bio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio ROE % Adjusted to Book Value Chart

Vaxil Bio Annual Data

Trend

May14

May15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-28.67

-12.60

-16.47

-7.02

Vaxil Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-22.71	-16.29	-16.08	-5.13	3.33

Competitive Comparison of Vaxil Bio's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Vaxil Bio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaxil Bio's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxil Bio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vaxil Bio's ROE % Adjusted to Book Value falls into.

Vaxil Bio ROE % Adjusted to Book Value Calculation

Vaxil Bio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-25.06%	/	3.57
	=	-7.02%

Vaxil Bio's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	11.88%	/	3.57
	=	3.33%

Vaxil Bio ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Vaxil Bio's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxil Bio (TSXV:VXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

VXLLF:USA

Address

C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

https://www.vaxil-bio.com

Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Vaxil Bio (TSXV:VXL) Headlines

No Headlines